| 000 | 01682 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516021900.0 | ||
| 264 | 0 | _c20160627 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1879-0712 | ||
| 024 | 7 |
_a10.1016/j.ejphar.2011.01.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQuesada, Arnulfo | |
| 245 | 0 | 0 |
_aComparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cMay 2011 |
||
| 300 |
_a30-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
| 650 | 0 | 4 |
_aBenzimidazoles _xchemistry |
| 650 | 0 | 4 |
_aCyclopropanes _xchemistry |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEssential Tremor _xdrug therapy |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 |
_aHarmaline _xmetabolism |
| 650 | 0 | 4 |
_aHydroxylation _xdrug effects |
| 650 | 0 | 4 |
_aMethylation _xdrug effects |
| 650 | 0 | 4 |
_aMibefradil _xchemistry |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNaphthalenes _xchemistry |
| 650 | 0 | 4 |
_aReceptors, GABA-A _xdeficiency |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTestosterone _xmetabolism |
| 700 | 1 | _aBui, Peter H | |
| 700 | 1 | _aHomanics, Gregg E | |
| 700 | 1 | _aHankinson, Oliver | |
| 700 | 1 | _aHandforth, Adrian | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 659 _gno. 1 _gp. 30-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejphar.2011.01.004 _zAvailable from publisher's website |
| 999 |
_c20537946 _d20537946 |
||